SCHEMBL353598

SCHEMBL353598

CC[CH]OC(C)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL355711 0.79
SCHEMBL2021110 0.76
SCHEMBL11782150 0.75 TSHR (0.33)
SCHEMBL4382765 0.74
SCHEMBL11779332 0.74 TSHR (0.34)
SCHEMBL59400 0.73
SCHEMBL1005395 0.72 TSHR (0.38)
SCHEMBL16115650 0.72 LMNA (0.32)
SCHEMBL9740379 0.72
SCHEMBL11251407 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180020662-A1 Substituted 1-cycloalkyl-2-oxotetrahydroquinolin-6-ylsulfonamides or salts thereof and use thereof to increase stress tolerance in plants BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2018-01-25 US claimed
EP-3256448-A1 SUBSTITUTED 1-CYCLOALKYL-2-OXOTETRAHYDROQUINOLIN-6-YL-SULFONAMIDES OR SALTS THEREOF AND USE THEREOF TO INCREASE STRESS TOLERANCE IN PLANTS Bayer CropScience Aktiengesellschaft (DE) 2017-12-20 EP claimed
WO-2016128365-A1 SUBSTITUTED 1-CYCLOALKYL-2-OXOTETRAHYDROQUINOLIN-6-YL-SULFONAMIDES OR SALTS THEREOF AND USE THEREOF TO INCREASE STRESS TOLERANCE IN PLANTS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2016-08-18 WO claimed
US-20070271710-A1 Disperse Dyes for Poly(Lactic Acid) Based Fibers DYSTAR TEXTIFARBEN GMBH & CO. DEUTSCHLAND KG (DE) 2007-11-29 US claimed
EP-1347979-B1 INDOLE DERIVATIVES AND THEIR USE AS 5-HT2B AND 5-HT2C RECEPTOR LIGANDS HOFFMANN LA ROCHE (CH) 2007-08-08 EP claimed
US-20070179285-A1 Method for producing alkoxy-substituted phthalocyanins LANXESS DEUTSCHLAND GMBH (DE) 2007-08-02 US claimed
WO-2007006417-A2 AXIALLY SUBSTITUTED PHTHALOCYANINE SULFONAMIDES AS LIGHT-ABSORBING COMPOUNDS IN THE DATA LAYER OF OPTICAL DATA CARRIERS LANXESS DEUTSCHLAND GMBH (DE) 2007-01-18 WO claimed
WO-2006040021-A2 MIXTURES OF AXIALLY SUBSTITUTED COBALT PHTHALOCYANINES LANXESS DEUTSCHLAND GMBH (DE) 2006-04-20 WO claimed
EP-1644378-A2 METHOD FOR PRODUCING ALKOXY-SUBSTITUTED PHTHALOCYANINS Lanxess Deutschland GmbH (DE) 2006-04-12 EP claimed
WO-2006003088-A1 DISPERSE DYES FOR POLY(LACTIC ACID) BASED FIBERS DYSTAR TEXTILFARBEN GMBH & CO. DEUTSCHLAND KG (DE) 2006-01-12 WO claimed
EP-1424323-A1 Method for preparing 3-alkoxyphtalocyanine Bayer Chemicals AG (DE) 2004-06-02 EP claimed
EP-1347979-A1 INDOLE DERIVATIVES AND THEIR USE AS 5-HT2B AND 5-HT2C RECEPTOR LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2003-10-01 EP claimed
US-6610685-B2 (S)-2-(6-ethoxy-2,3-dihydro-1H-3a-aza-cyclopenta(a)inden-8-yl)-1-methyl-ethylamine for example; treating diabetes; in combination with a lipase inhibitor such as orlistat HOFFMANN-LA ROCHE INC. 2003-08-26 US claimed
US-20020160997-A1 (S)-2-(6-ethoxy-2,3-dihydro-1H-3a-aza-cyclopenta(a)inden-8-yl)-1-methyl-ethylamine for example; treating diabetes; in combination with a lipase inhibitor such as orlistat F.HOFFANN-LA ROCHE AG (CH) 2002-10-31 US claimed
WO-2002051844-A1 INDOLE DERIVATIVES AND THEIR USE AS 5-HT2B AND 5-HT2C RECEPTOR LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-04 WO claimed
EP-0543919-B1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS IN THE MANUFACTURE OF A MEDICAMENT FOR TREATMENT OF CNS DISEASES SEARLE & CO (US) 1996-04-10 EP claimed
US-5453352-A Silver halide color photographic light-sensitive material KONICA CORPORATION (JP) 1995-09-26 US claimed
EP-0614116-A1 Silver halide color photographic light-sensitive material KONICA CORPORATION (JP) 1994-09-07 EP claimed
EP-0543919-A1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS FOR TREATMENT OF CNS DISEASES. SEARLE & CO (US) 1993-06-02 EP claimed
WO-1992003131-A1 USE OF HETEROCYCLIC AMINO-ALCOHOL COMPOUNDS FOR TREATMENT OF CNS DISEASES G.D. SEARLE & CO. (US) 1992-03-05 WO claimed